Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Phosphatidylinositol-3-OH kinases are Rab5 effectors

Nature Cell Biology volume 1, pages 249–252 (1999)Cite this article

Access through your institution
Buy or subscribe

Phosphatidylinositol-3-OH kinases (PI(3)Ks) constitute a family of lipid-modifying enzymes that are involved in signal transduction, cytoskeletal organization and membrane transport1. Three different classes of PI(3)K have been described, which differ in their specificities for phosphatidylinositol, phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate substrates, as well as in their regulation. PI(3)Ks are needed for receptor trafficking in the endocytic pathway in mammalian cells and for transport from the Golgi to the vacuole in yeast (reviewed in ref. 1). The docking and fusion of early endosomes, which is regulated by the small GTPase Rab5 (ref. 2), requires PI(3)K activity3. In addition, PI(3)Ks regulate the recruitment to membranes of EEA1, an effector of the small GTPase Rab5 and a core component of the docking and fusion machinery4,5 that binds phosphatidylinositol-3-phosphate (PtdIns(3)P) through a FYVE-finger motif6. We have recently identified over 20 cytosolic proteins that interact with the active form of Rab5 (ref. 5). Here we report the identification of two distinct PI(3)Ks, hVPS34 and p85α–p110β, among these cytosolic proteins. We suggest a new mechanism by which Rab5 can modify its membrane environment by coupling the local production of phosphoinositides to the selective recruitment of Rab5 effector proteins.

Given the presence of a class-I-PI(3)K regulatory subunit in the Rab5-GTPγS eluate, we would expect the catalytic subunit to be either p110α or p110β (ref. 1). By using isoform-specific antibodies we established that p110β, but not p110α, was present in the eluate (Fig. 1c). We detected no interaction of p110β with fusion proteins consisting of glutathione-S-transferase (GST) fused to Rab4-GTPγS or Rab11-GTPγS. We also tested a class-II PI(3)K (PI3K-C2α), but failed to detect binding of this enzyme to Rab5-GTPγS or Rab5-GDP. These results indicate that Rab5 specifically and GTP-dependently interacts with the class-I PI(3)K p85α–p110β.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The PI(3)Ks p85α–p110β and p150–hVPS34 bind specifically to a Rab5-GTPγS affinity column.
Figure 2: Role of PI(3)Ks in endosome fusion and recruitment of EEA1.

References

  1. Rameh, L. E. & Cantley, L. C. J. Biol. Chem. 274, 8347–8350 (1999).

    Article  CAS  Google Scholar 

  2. Horiuchi, H. et al. Cell 90, 1149–1159 (1997).

    Article  CAS  Google Scholar 

  3. Li, G. et al. Proc. Natl Acad. Sci. USA 92, 10207–10211 (1995).

    Article  CAS  Google Scholar 

  4. Simonsen, A. et al. Nature 394, 494–498 (1998).

    Article  CAS  Google Scholar 

  5. Christoforidis, S., McBride, H. M., Burgoyne, R. D. & Zerial, M. Nature 397, 621–625 (1999).

    Article  CAS  Google Scholar 

  6. Wiedemann, C. & Cockcroft, S. Nature 394, 426–427 (1998).

    Article  CAS  Google Scholar 

  7. Rodriguez-Viciana, P. et al. Nature 370, 527–532 (1994).

    Article  CAS  Google Scholar 

  8. Siddhanta, U., McIlroy, J., Shah, A., Zhang, Y. & Backer, J. M. J. Cell Biol. 143 1647–1659 (1998).

    Article  CAS  Google Scholar 

  9. Mu, F. et al. J. Biol. Chem. 270, 13503–13511 (1995).

    Article  CAS  Google Scholar 

  10. Rapoport, I. et al. EMBO J. 16, 2240–2250 (1997).

    Article  CAS  Google Scholar 

  11. McLauchlan, H. et al. Curr Biol 8, 34–45 (1998).

    Article  CAS  Google Scholar 

  12. Bucci, C. et al. Cell 70, 715–728 (1992).

    Article  CAS  Google Scholar 

  13. Wang, Q., Bilan, P. J., Tsakiridis, T., Hinek, A. & Klip, A. Biochem J 331, 917–928 (1998).

    Article  CAS  Google Scholar 

  14. Vanhaesebroeck, B. et al. Nature Cell Biol. 1, 69–71 (1999).

    Article  CAS  Google Scholar 

  15. Schu, P. V. et al. Science 260, 88–91 (1993).

    Article  CAS  Google Scholar 

  16. Burd, C. G. & Emr, S. D. Mol. Cell 2, 157–162 (1998).

    Article  CAS  Google Scholar 

  17. Jones, A. T., Mills, I. G., Scheidig, A. J., Alexandrov, K. & Clague, M. J. Mol. Biol. Cell. 9, 323–332 (1998).

    Article  CAS  Google Scholar 

  18. Rybin, V. et al. Nature 383, 266–269 (1996).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank J. Downward for p85α complementary DNA; U. Maier for the p110β construct; R. Lippe for the complex consisting of Rab5 and guanine-nucleotide-dissociation factor; and A. Giner for technical assistance. S.C. and M.M. are recipients of Max Planck and Human Frontier Science Program fellowships, respectively. This work was supported by the Max Planck Gesellschaft and by grants from the Human Frontier Science Program (RG-432/96), EU TMR (ERB-CT96-0020) and Biomed (BMH4-97-2410) (M.Z.).

Correspondence and requests for materials should be addressed to M.Z.

Author information

Authors and Affiliations

  1. Max Planck Institute for Molecular Cell Biology and Genetics, Pfotenhauerstrasse, Dresden, 01307, Germany

    Savvas Christoforidis, Marta Miaczynska, Liyun Zhao & Marino Zerial

  2. European Molecular Biology Laboratory (EMBL), Meyerhofstrasse 1, Heidelberg, 69117, Germany

    Savvas Christoforidis, Marta Miaczynska, Keith Ashman, Matthias Wilm & Marino Zerial

  3. Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, 10461, USA

    Shu-Chin Yip & Jonathan M. Backer

  4. Ludwig Institute of Cancer Research, University College London, Riding House Street, London, W1P 8BT, UK

    Michael D. Waterfield

Authors
  1. Savvas Christoforidis
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Marta Miaczynska
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Keith Ashman
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Matthias Wilm
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Liyun Zhao
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Shu-Chin Yip
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Michael D. Waterfield
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. Jonathan M. Backer
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. Marino Zerial
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Marino Zerial.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Christoforidis, S., Miaczynska, M., Ashman, K. et al. Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat Cell Biol 1, 249–252 (1999). https://doi.org/10.1038/12075

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/12075

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing